34 Followers on Owler

Protalix

is an Israel-based biopharmaceutical company that develops and commercializes plant-based proteins for the treatment of fibrosis and inflammatory bowel diseases... Read more
OverviewCompetitorsFundingNews & Insights

Protalix

is an Israel-based biopharmaceutical company that develops and commercializes plant-based proteins for the treatment of fibrosis and inflammatory bowel diseases... Read more
Protalix President & CEO: Dror Bashan

President & CEO

Dror Bashan

CEO Approval Rating

87/100

1992

PublicNYSEPLX

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$76.4M
Employees
200
Funding
$121.8M

News

Partnership
Dec 17, 2025
Benzinga
Protalix Biotherapeutics and Secarna Pharmaceuticals Enter into Collaboration and Option Agreement
Conference Presentation
Sep 02, 2025
Yahoo
Protalix BioTherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Protalix Competitors

1Dyadic
2iBio
3Medicago
4Greenovation
5Crucell
6Icosavax
7MNPHARM
8KBI
9Tedor
10Alvotech
Unlock 11 + competitors

Trending Companies